相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria
Bruce A. Perkins et al.
KIDNEY INTERNATIONAL (2010)
Risk Factors for End-Stage Renal Disease 25-Year Follow-up
Chi-yuan Hsu et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes An Inception Cohort Study
Peter Hovind et al.
DIABETES (2009)
Integrating albuminuria and GFR in the assessment of diabetic nephropathy
George Jerums et al.
NATURE REVIEWS NEPHROLOGY (2009)
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD
Lesley A. Stevens et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes
Elizabeth T. Rosolowsky et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes
Erosha Premaratne et al.
DIABETES CARE (2008)
Uric Acid Levels Increase Risk for New-Onset Kidney Disease
Rajesh Mohandas et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions
Mehmet Kanbay et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2007)
Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes
Bruce A. Perkins et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial
Areef Ishani et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level
YP Siu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
MA Becker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: Results of a 4-year follow-up study
BA Perkins et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Risk factors for development of decreased kidney function in a Southeast Asian population: A 12-year cohort study
S Domrongkitchaiporn et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort
K Iseki et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Regression of microalbuminuria in type 1 diabetes
BA Perkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Allopurinol improves endothelial dysfunction in chronic heart failure
CA Farquharson et al.
CIRCULATION (2002)
The need for early predictors of diabetic nephropathy risk - Is albumin excretion rate sufficient?
ML Caramori et al.
DIABETES (2000)
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension
R Butler et al.
HYPERTENSION (2000)